Alexander Drilon, MD

Medical Oncologist

Clinical Director, Early Drug Development Service

Conditions Treated

Pictured: Alexander Drilon
LocationA pin, used as a metaphor for the concept of location. Locations Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.
Phone iconAn icon showing a telephone. New Patient Appointments Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.
Phone iconAn icon showing a telephone. Phone Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

About Me

I am a medical oncologist who specializes in the treatment of lung cancer. I work with a team of experts including surgeons, radiation oncologists, pathologists, and nurses. Our goal is to provide the best possible care and support for patients and their families.

As a member of the Thoracic Oncology Service, my research is focused on developing new treatments for lung cancer. I have a particular interest in studying ways to target molecular changes in patients’ tumors with new medicines.

I also specialize in early-phase clinical trials and am a member of our Developmental Therapeutics group. Our aim is to bring new drugs to patients with all types of cancer, particularly those for whom standard treatments have been exhausted.

I speak English, Spanish, and Filipino.

  • Clinical Expertise: Lung Cancer; Early-Phase Clinical Trials
  • Languages Spoken: English; Spanish
  • Education: MD, University of the Philippines
  • Residencies: Internal Medicine - St. Luke's-Roosevelt Hospital Center
  • Fellowships: Medical Oncology - Memorial Sloan Kettering Cancer Center
  • Board Certifications: Internal Medicine; Medical Oncology

New Patient Appointments

Schedule an appointment Arrow rightAn icon showing an arrow pointing to the right.

Call 866-675-5864 (866-MSK-LUNG)

See My Colleagues

Publications

Visit PubMed for a full listing of Alexander Drilon’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.

Clinical Trials Led by Alexander Drilon

Clinical Trials Co-Investigated by Alexander Drilon

Insurance

Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicare and New York State Medicaid also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.

Related topics:

MSK medical oncologist Alexander Drilon First Targeted Cancer Drug Approved Based on Mutation Rather than Tumor Type Arrow rightAn icon showing an arrow pointing to the right.
MSK lung cancer expert Alexander Drilon and Anna Five Thousand Miles from Home, Anna Achieves Remission for Advanced Lung Cancer Arrow rightAn icon showing an arrow pointing to the right.
Crowded hall with ASCO signage Highlights from ASCO 2018: Immunotherapy for Endometrial Cancer, Benefits of Exercise, and Promising New Targeted Drugs Arrow rightAn icon showing an arrow pointing to the right.
Gregory Riely Genomic Analysis Brings Personalized Treatment to Lung Cancers Arrow rightAn icon showing an arrow pointing to the right.
Physician standing in front of a whiteboard Novel Drug Advancing to Phase II Basket Trial of Solid Tumors Arrow rightAn icon showing an arrow pointing to the right.
Three syringes stuck into an orange and white bull’s-eye Drug Targeting Genetic Mutation Works across All Tumor Types Arrow rightAn icon showing an arrow pointing to the right.